Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
British Journal of Cancer, 09/29/2011
Clinical Article
Nagata M et al. – The novel findings demonstrate that cellular inhibitor of apoptosis protein 2 (cIAP2) may represent a potentially useful therapeutic target for improving the treatment and survival of oral squamous cell carcinoma (OSCC) patients, particularly in the setting of 5–fluorouracil (5–FU) resistance.







